Overall, out of the 19 methylation sites corresponding to TNFRSF12A identified in the TCGA, significant differences were seen in five methylation sites between HCC cancerous and paracancerous tissues (p <1.0E−7, |logFC| >0.8). This evidence concerns the gene TNFRSF12A and hepatocellular carcinoma.